Breast Implant Illness Specialist — Austin, Texas
Robert Whitfield, MD is a board-certified plastic surgeon in Austin, Texas specializing in breast implant illness evaluation, explant surgery with total capsulectomy, and post-operative recovery through the SHARP Method. He has performed over 2,000 explant procedures and is the author of the largest peri-implant capsule study in medical literature.
At a Glance
- 2,000+ explant procedures performed
- 694 peri-implant capsule specimens analyzed via PCR — the largest dataset in medical literature (PMID 39338504)
- 29% bacterial contamination rate identified — none detectable by standard culture
- 40+ states and 15 countries represented in patient base
- FDA testimony: General and Plastic Surgery Devices Panel on breast implant safety
- Expert citation: Named source on breastcancer.org Breast Implant Illness page
- 2 books, 4,000+ YouTube videos, 160+ podcast episodes on BII and explant surgery
What Sets a BII Specialist Apart
Not every plastic surgeon who performs implant removal is a breast implant illness specialist. The distinction matters.
A BII specialist understands the published research on how breast implants produce systemic illness — the biofilm mechanism, the inflammatory pathways, the immune activation pattern identified in recent peer-reviewed research. A BII specialist performs total capsulectomy, not just implant removal. A BII specialist tests the capsule tissue to understand what has been happening inside the body. And a BII specialist has a structured approach to recovery that accounts for the immune burden the body has been carrying.
Volume also matters. A surgeon who performs 10 explant procedures per year does not have the same pattern recognition, technique refinement, or outcomes data as a surgeon who has performed over 2,000.
Dr. Whitfield's Credentials
Board Certification
Board-Certified Plastic Surgeon — American Board of Plastic Surgery
Surgical Volume
Over 2,000 explant procedures performed; patients from 40+ states and 15 countries
Published Research
- Largest peri-implant capsule PCR study in medical literature — 694 consecutive specimens, 29% bacterial contamination, 103 distinct bacterial species. Published September 2024: Microorganisms 12(9):1830. PMID 39338504. DOI: 10.3390/microorganisms12091830.
- Fat grafting safety research, Aesthetic Surgery Journal (PMID 29044365)
Regulatory
Testified before the FDA General and Plastic Surgery Devices Panel on breast implant safety
Leadership
Past President, Aesthetic Surgery Education and Research Foundation (ASERF) — established the BII Study Task Force and approved funding for the Aesthetic Neural Network (ANN) to enable plastic surgeons to contribute clinical data to BII research
Expert Citation
Cited as a named expert on breast implant illness by breastcancer.org — one of the most visited breast health resources online
Books
The SHARP Method | Breast Implants, Explant Surgery and Breast Implant Illness
What a BII Specialist Evaluation Includes
A BII evaluation with Dr. Whitfield is not a brief office visit. It is a comprehensive assessment designed to understand the full picture of a patient's implant history, symptom timeline, immune status, and surgical candidacy.
Symptom and history review
Timeline of symptoms relative to implant placement, exchange, or rupture. Review of prior specialist evaluations, diagnoses, and treatments. Assessment of symptom severity across body systems.
Laboratory evaluation
Inflammatory markers, thyroid panel, autoimmune markers, hormone panel, nutritional markers relevant to immune function. Lab results are interpreted in the context of BII, where many standard markers fall within normal range despite active immune activation.
Imaging review
MRI for silicone implants when rupture or intracapsular abnormality is a concern. Review of prior imaging.
Surgical candidacy assessment
Discussion of total capsulectomy approach, fat transfer options for natural contour restoration, and the SHARP Method protocol that follows surgery.
PCR capsule testing plan
Dr. Whitfield submits every capsule specimen for PCR molecular analysis at the time of surgery. This identifies the specific bacterial species present in the capsule — information standard culture testing cannot provide — and directly informs the post-operative recovery plan.
The Surgical Difference: Total Capsulectomy
Many surgeons remove the implant. Dr. Whitfield removes the implant and the entire capsule — the fibrous tissue that formed around the implant and harbors the biofilm documented in his published research.
Partial capsulectomy, or implant removal without capsule removal, leaves the biofilm-colonized tissue in place. The immune system continues responding to the bacterial antigen. Symptoms may not improve, or may improve only partially.
Total capsulectomy eliminates the source. The body is no longer reacting to an ongoing bacterial signal.
PCR Capsule Testing: The Standard of Care Dr. Whitfield Established
Standard culture testing of peri-implant capsule tissue returns negative results in virtually all BII cases — creating the clinical impression that no infection is present.
Dr. Whitfield's 2024 study demonstrated that standard culture is simply the wrong test. PCR molecular analysis identified bacterial contamination in 29% of 694 capsule specimens that culture testing missed entirely. (Microorganisms 2024; PMID 39338504.)
Dr. Whitfield submits every capsule to PCR analysis. The results — which bacterial species were present, in what quantities, and in what combinations — inform the specific components of the SHARP Method recovery protocol applied to each patient.
The SHARP Method
The Strategic Holistic Accelerated Recovery Program is Dr. Whitfield's post-operative recovery protocol for explant patients. It is not a one-size-fits-all program. It is personalized based on:
- PCR capsule test results
- Pre-operative immune and hormone labs
- Patient symptom profile and comorbidities
- Surgical findings
The SHARP Method addresses the body's recovery needs following the removal of the immune burden the capsule has been generating — supporting immune system recalibration, hormonal normalization, nutritional repletion, and return of energy and cognitive function.
Traveling to Austin for BII Treatment
Dr. Whitfield's patient base is national and international. The majority of BII patients do not live in Austin.
The team coordinates care for out-of-state and international patients, including:
- Discovery calls to assess candidacy before travel
- Pre-operative lab coordination with local providers
- Surgical scheduling that minimizes travel requirements
- Post-operative follow-up via telemedicine
Austin-Bergstrom International Airport (AUS) is 20 minutes from the surgical practice.
Why Patients Travel from 40+ States
“Usually, my clients with BII find me after exhausting all other medical avenues and going through exhaustive medical testing.”
— Dr. Robert Whitfield, as cited on breastcancer.org
The patients who travel to Austin are typically not newly symptomatic. They have seen multiple specialists, received multiple diagnoses, and tried multiple treatments. They come to Dr. Whitfield because the root cause — the implant capsule — has not been addressed.
The combination of published research expertise, surgical volume, PCR capsule testing, and the SHARP Method recovery protocol is not replicated elsewhere.
Book a Discovery Call
Discovery calls are available for patients considering explant surgery evaluation. The call assesses symptom history, implant history, and whether an in-person evaluation is appropriate.
Dr. Whitfield's practice is located at 2530 Walsh Tarlton Lane, Suite 100, Austin, Texas.
Related Topics
You Deserve a Surgeon Who Prepares You, Not Just Operates on You.
Dr. Robert Whitfield has guided thousands of patients through surgical decisions with clarity, data, and a personalized plan. Your consultation is where that plan begins.
Not ready to book? Download the free Inflammation Support Guide to start your journey.